Santhera Pharmaceuticals Holding AG Share Price
Stocks
SANN
CH1276028821
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Swiss Exchange
10:01:55 27/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 15.06 CHF | +5.76% |
|
+2.45% | +19.52% |
| 23/10 | Santhera's Partner Seeks Marketing Permit in South Korea for Duchenne Muscular Dystrophy Treatment | MT |
| 23/10 | Nxera Pharma Files South Korean Marketing Application for DMD Drug | MT |
| Market Cap | 23Cr 28Cr 25Cr 21Cr 39Cr 2.64TCr 40Cr 276.29Cr 109.73Cr 1.38TCr 104.38Cr 102.15Cr 4.39TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 25Cr 30Cr 27Cr 23Cr 42Cr 2.87TCr 43Cr 300.63Cr 119.39Cr 1.51TCr 113.58Cr 111.15Cr 4.78TCr | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.11x |
| Free-Float |
84.85% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| SANN | Delayed | |
CBOE
| 0QN1 | Real-time | |
|
Tradegate
| S3F0 | Real-time | |
|
Boerse Muenchen
| S3F0 | Real-time | |
|
OTC Markets
| SPHD.F | Delayed | |
|
Deutsche Boerse AG
| S3F0 | Delayed | |
|
Börse Stuttgart
| S3F0 | Delayed |
Last Transcript: Santhera Pharmaceuticals Holding AG
| 1 day | +5.76% | ||
| 1 week | +2.45% | ||
| Current month | -2.84% | ||
| 1 month | -1.05% | ||
| 3 months | -1.31% | ||
| 6 months | -17.97% | ||
| Current year | +19.52% |
| 1 week | 13.84 |  | 15.1 |
| 1 month | 13.42 | | 15.98 |
| Current year | 11.7 | | 18.84 |
| 1 year | 10.06 | | 18.84 |
| 3 years | 7.21 | | 18.84 |
| 5 years | 5 | | 20.3 |
| 10 years | 5 | | 820 |
| Manager | Title | Age | Since |
|---|---|---|---|
Orlando Oliveira
CEO | Chief Executive Officer | 50 | 15/07/2026 |
Catherine Isted
DFI | Director of Finance/CFO | 51 | 24/02/2025 |
Marc Schrader
COO | Chief Operating Officer | 55 | 01/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Meier
CHM | Chairman | 64 | 30/06/2022 |
| Director/Board Member | 58 | 04/04/2017 | |
Bradley Meyer
BRD | Director/Board Member | 47 | 27/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/01/24 | Buy | 30,228 | 0.2396% | |||
| 06/07/23 | Buy | 2,000 | 0.0016% | |||
| 11/01/22 | Buy | 30,000 | 0.0549% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.76% | +2.45% | +42.08% | +30.73% | 26Cr | |
| +0.22% | -0.14% | +55.12% | +128.82% | 1,14000Cr | |
| +0.91% | +3.61% | +41.21% | +84.57% | 64TCr | |
| -0.12% | -0.93% | +25.59% | +106.14% | 51TCr | |
| +0.63% | +2.33% | +49.21% | +67.82% | 38TCr | |
| +0.86% | -4.37% | +61.16% | +37.93% | 35TCr | |
| +1.02% | +1.80% | +24.84% | +53.75% | 29TCr | |
| -0.25% | +1.62% | +2.20% | +26.65% | 27TCr | |
| +0.75% | +2.05% | +53.85% | +71.25% | 24TCr | |
| +0.25% | +1.64% | +32.05% | +107.62% | 20TCr | |
| Average | +1.00% | +0.92% | +38.73% | +71.53% | 40.14TCr | |
| Weighted average by Cap. | +0.44% | +0.96% | +42.20% | +88.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.47Cr 11Cr 10Cr 8.59Cr 16Cr 1.09TCr 16Cr 113.54Cr 45Cr 568.94Cr 43Cr 42Cr 1.8TCr | 12Cr 14Cr 13Cr 10Cr 20Cr 1.32TCr 20Cr 138.54Cr 55Cr 694.2Cr 52Cr 51Cr 2.2TCr |
| Net income | - | - |
| Net Debt | 2.03Cr 2.45Cr 2.2Cr 1.84Cr 3.44Cr 232.67Cr 3.48Cr 24Cr 9.67Cr 121.96Cr 9.2Cr 9Cr 386.75Cr | 1.34Cr 1.62Cr 1.45Cr 1.22Cr 2.27Cr 153.59Cr 2.3Cr 16Cr 6.38Cr 81Cr 6.07Cr 5.94Cr 255.29Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | CHF 15.06 | +5.76% | 1,66,430 |
| 26/26/26 | CHF 14.24 | +2.89% | 67,826 |
| 23/26/23 | CHF 13.84 | -1.98% | 41,973 |
| 22/26/22 | CHF 14.12 | -4.72% | 19,740 |
| 21/26/21 | CHF 14.82 | +0.82% | 42,499 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SANN Stock
Select your edition
All financial news and data tailored to specific country editions
